Cosmo Highlights Leadership in Real Time Medical AI at NVIDIA GTC 2026

Rhea-AI Summary

Cosmo (OTC: CMOPF) will present at NVIDIA GTC 2026 in San Jose, March 16–19. On March 19 at 10:00 CET Cosmo delivers a session titled "Engineering Medical Grade Platforms for Real Time AI" featuring MedTech AI leaders Nhan Ngo Dinh and Pietro Salvagnini.

The talk highlights Cosmo's real‑time clinical AI systems such as GI Genius and its use of NVIDIA accelerated computing for intra‑procedure detection, decision support, and workflow optimization.

News Market Reaction – CMOPF

-1.70%

-1.70% Session close to close

In the Mar 16 session, CMOPF declined 1.70%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Dublin, Ireland--(Newsfile Corp. - March 16, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its participation at NVIDIA GTC 2026, the world’s leading conference for artificial intelligence (AI) and accelerated computing, taking place in San Jose (CA), USA, from March 16 to March 19.

At the conference, Cosmo will present a technical session titled “Engineering Medical Grade Platforms for Real Time AI”, highlighting the Company’s approach to designing and deploying artificial intelligence systems for use in clinical environments. The session will be delivered by Nhan Ngo Dinh, President of MedTech AI at Cosmo, and Pietro Salvagnini, Director of AI Factory, and will explore the engineering challenges behind building medical grade AI platforms capable of operating in real time during medical procedures.

Cosmo develops real time artificial intelligence systems designed to operate during medical procedures, assisting physicians with detection, decision support, and workflow optimization. Through platforms such as GI Genius™, Cosmo has demonstrated how AI can move beyond research and deliver measurable value in everyday clinical practice.

Cosmo’s engineering teams leverage advanced accelerated computing technologies from NVIDIA to develop AI systems capable of operating in real time during medical procedures.

Session Details:

• “Engineering Medical Grade Platforms for Real Time AI”
• NVIDIA GTC 2026
• Thursday, March 19
• 10:00 to 10:50 CET

Giovanni Di Napoli, CEO of Cosmo, commented: “Artificial intelligence will fundamentally reshape medicine. At Cosmo, we are focused on building medical grade AI systems that operate in real clinical environments and support physicians during procedures. Presenting our work at NVIDIA GTC reflects the progress our teams are making in bringing AI from research into everyday medical practice.”

Cosmo’s participation at this year’s NVIDIA GTC reflects the Company’s continued commitment to advancing artificial intelligence in healthcare and strengthening its position at the intersection of medical technology and AI.

About Cosmo

Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit www.cosmohealthconfidence.com

For further information, please contact:

investor.relations@cosmohc.com

Attachments

PDF - English

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288656

FAQ

What will Cosmo (CMOPF) present at NVIDIA GTC 2026 and when is the session?

Cosmo will present a technical session titled "Engineering Medical Grade Platforms for Real Time AI" on March 19, 10:00–10:50 CET. According to Cosmo, the session will describe engineering approaches for deploying AI systems that operate during medical procedures.

Who are the Cosmo speakers at NVIDIA GTC 2026 for CMOPF and what are their roles?

Speakers include Nhan Ngo Dinh, President of MedTech AI, and Pietro Salvagnini, Director of AI Factory. According to Cosmo, both will discuss engineering challenges in building medical‑grade, real‑time AI platforms for clinical use.

How does Cosmo describe its real time AI systems like GI Genius (CMOPF)?

Cosmo describes systems such as GI Genius as real‑time AI designed to assist physicians with detection, decision support, and workflow optimization during procedures. According to Cosmo, these platforms move AI beyond research into everyday clinical practice.

What role does NVIDIA technology play in Cosmo's CMOPF AI platforms?

Cosmo says its engineering teams leverage NVIDIA accelerated computing technologies to enable AI systems to operate in real time during procedures. According to Cosmo, NVIDIA hardware and software support the performance requirements of medical‑grade AI.

Where and when is NVIDIA GTC 2026 taking place for investors following CMOPF news?

NVIDIA GTC 2026 takes place in San Jose, California from March 16 to March 19, 2026. According to Cosmo, the company will participate throughout the event and present its technical session on March 19 at 10:00 CET.

How does Cosmo position its MedTech AI strategy in the CMOPF announcement?

Cosmo positions MedTech AI as central to advancing healthcare by building medical‑grade systems for clinical environments and procedures. According to Cosmo, participation at NVIDIA GTC demonstrates ongoing commitment to applying AI in everyday medical practice.